Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Limelight Networks Inc (LLNW - Get Report), where a total of 2,055 contracts have traded so far, representing approximately 205,500 underlying shares. That amounts to about 59.8% of LLNW's average daily trading volume over the past month of 343,915 shares. Especially high volume was seen for the $2 strike put option expiring September 15, 2017, with 2,000 contracts trading so far today, representing approximately 200,000 underlying shares of LLNW. Below is a chart showing LLNW's trailing twelve month trading history, with the $2 strike highlighted in orange:Sears Holdings Corp ( SHLD) saw options trading volume of 6,781 contracts, representing approximately 678,100 underlying shares or approximately 57.2% of SHLD's average daily trading volume over the past month, of 1.2 million shares. Particularly high volume was seen for the $5 strike put option expiring January 18, 2019, with 1,015 contracts trading so far today, representing approximately 101,500 underlying shares of SHLD. Below is a chart showing SHLD's trailing twelve month trading history, with the $5 strike highlighted in orange: And Spark Therapeutics Inc ( ONCE) options are showing a volume of 1,934 contracts thus far today. That number of contracts represents approximately 193,400 underlying shares, working out to a sizeable 53% of ONCE's average daily trading volume over the past month, of 364,745 shares. Particularly high volume was seen for the $65 strike call option expiring July 21, 2017, with 528 contracts trading so far today, representing approximately 52,800 underlying shares of ONCE. Below is a chart showing ONCE's trailing twelve month trading history, with the $65 strike highlighted in orange: For the various different available expirations for LLNW options, SHLD options, or ONCE options, visit StockOptionsChannel.com.
More from Stocks
Novartis Still a Buy Despite Controversy Over Blockbuster Drug
Despite the issues that have bubbled up related to its breakthrough drug for spinal muscular atrophy, Zolgensma, Novartis "has the newest pipeline with many drugs just beginning to have an impact on the company's bottom line," Cramer told members of his Action Alerts PLUS club for investors during an exclusive video-conference call.
Could Netflix Survive on Just Its Own Original Content?
Netflix says that viewers shell out for original shows like Stranger Things and Orange is the New Black -- but production costs have ballooned roughly 30% since last year, which has many investors spooked.
Jim Cramer: Mastercard Is One Thing Money Can Buy
The slogan was: There are some things money can't buy; for everything else, there's Mastercard. Fast forward more than two decades and the world of fintech and digital payment processing has changed, and Mastercard has changed right along with it.